Back to search
FDAFDA · Food and drugs·Recall number D-0466-2023

Buprenorphine Transdermal System, CIII 20 mcg/hour, 4 Transdermal Systems One package of 4 disposal units, Rx Only, Manufactured by: Aveva Drug Delivery Systems Inc. Miramar, FL. 33025, Manufactured for: Apotex Corp Weston, FL. 33326, NDC 60505-7079-05

Published March 22, 2023 · Recall initiated: February 15, 2023

Summary

FDA records drug Class III recall D-0466-2023, published March 22, 2023 and initiated February 15, 2023. Recalling firm: AVEVA Drug Delivery Systems, Inc.; Status: Terminated; Reported quantity: 5,208 cartons; Lot: Lot#: 51836 Exp: 07/2023. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
AVEVA Drug Delivery Systems, Inc.
Distributor
Nationwide
Lot
Lot#: 51836 Exp: 07/2023
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Buprenorphine Transdermal System, CIII 20 mcg/hour, 4 Transdermal Systems One package of 4 disposal units, Rx Only, Manufactured by: Aveva Drug Delivery Systems Inc. Miramar, FL. 33025, Manufactured for: Apotex Corp Weston, FL. 33326, NDC 60505-7079-05 recalled?

Yes. FDA published recall D-0466-2023 on March 22, 2023. Reported hazard: Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.

What should I do if I have this product?

Voluntary: Firm initiated · Letter